Carmine Stengone

Carmine Stengone

Vorstandsvorsitzender bei CONTINEUM THERAPEUTICS, INC.

Vermögen: 177 896 $ am 31.05.2024

48 Jahre
Health Technology
Consumer Services
Health Services

Ursprung des Netzwerks ersten Grades von Carmine Stengone

EinheitArt der EinheitIndustrie
339
College/University Other Consumer Services 339
Wake Forest University
105
College/University Other Consumer Services 105
21
Extinct Pharmaceuticals: Major 21
Johnson Graduate School of Management
13
College/University Other Consumer Services 13
12
Holding Company Medical/Nursing Services 12
Public Company Pharmaceuticals: Major 11
Public Company Biotechnology 7
6
Subsidiary Pharmaceuticals: Major 6
4
Subsidiary Miscellaneous Commercial Services 4
1
Holding Company Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Carmine Stengone

UnternehmenSektorVerknüpfte PersonenHauptposition
ALLERGAN, INC. Pharmaceuticals: Major

David Hollander

Lori Lyons-Williams

Chief Tech/Sci/R&D Officer

Sales & Marketing

PFIZER, INC. Pharmaceuticals: Major

Jay Lichter

Evert Schimmelpennink

Corporate Officer/Principal

Corporate Officer/Principal

NUMEREX CORP. Computer Communications

Kenneth Gayron

Chief Executive Officer

SEQUENOM, INC. Medical Specialties

Jay Lichter

Brian Baker

Corporate Officer/Principal

Comptroller/Controller/Auditor

Medical Specialties

Bradley Campbell

Christina Rossi

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Timothy J. O'Brien

Portfolio Manager-Equities

GLOBUS MEDICAL, INC. Medical Specialties

Anthony Williams

President

Electronic Equipment/Instruments

Anthony Williams

Director/Board Member

Stanford University College/University

David Hollander

Stefan Heller

Undergraduate Degree

Corporate Officer/Principal

KAGOME CO., LTD. Food: Specialty/Candy

Hiroshi Mori

Director/Board Member

Investment Banks/Brokers

Michael Reid Clarfeld

Jeff Haywood

Ho Kent Ching-Tak

Corporate Officer/Principal

Analyst-Equity

Corporate Officer/Principal

Rice University College/University

Chad Fargason

Jesus E. Gonzalez

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Anthony Williams

Private Equity Analyst

Amherst College College/University

John Robert Born

Edward N. Moss

Undergraduate Degree

Undergraduate Degree

Boston College College/University

Austin M. Kairnes

Kenneth Gayron

Undergraduate Degree

Undergraduate Degree

The University of Chicago College/University

Jeff Bourke

Matthew Rhodes-Kropf

Masters Business Admin

Corporate Officer/Principal

College/University

Kenneth Gayron

Brian Strem

David Pykon

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Princeton University College/University

Joe B. Alala

Jesus E. Gonzalez

Corporate Officer/Principal

Doctorate Degree

University of California, Berkeley College/University

Peter G. Schultz

Eric Daniels

Corporate Officer/Principal

Undergraduate Degree

Miscellaneous Commercial Services

John Robert Born

Timothy Scott

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Praveen Tyle

Kenneth Gayron

Chief Executive Officer

Director of Finance/CFO

Miscellaneous Commercial Services

Hiroshi Mori

Corporate Officer/Principal

United States Navy (District of Columbia) Sovereign

Scott Alan Cullerton

Scott Dysert

Corporate Officer/Principal

Corporate Officer/Principal

The University of Alabama at Birmingham College/University

Ashley A. Morris

Masters Business Admin

REGULUS THERAPEUTICS INC. Pharmaceuticals: Major

Mark Foletta

Preston Klassen

Director/Board Member

President

Investment Managers

Ashley A. Morris

Corporate Officer/Principal

Medical/Nursing Services

Aron Shapiro

David Hollander

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Biotechnology

Brian Baker

Laura Shawver

Director of Finance/CFO

Director/Board Member

The University of North Carolina at Charlotte College/University

Dan Ariely

Anthony Williams

Doctorate Degree

Undergraduate Degree

Medical/Nursing Services

Anthony Williams

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Jonathan Leonard Steinmetz

David Hollander

Lily Daniel

Undergraduate Degree

Masters Business Admin

Graduate Degree

Harvard Business School College/University

Bradley Campbell

Scott Alan Cullerton

Maneesh Modi

Christina Rossi

Johnson Erik

Boyea-Robinson Tynesia

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Kellogg School of Management College/University

Aaron M. Perlmutter

Justin Ward

Masters Business Admin

Masters Business Admin

Investment Managers

Alexey Vinogradov

Chief Executive Officer

SYNTHORX, INC. Biotechnology

Jay Lichter

Laura Shawver

Chief Executive Officer

Chief Executive Officer

Investment Managers

Anthony Williams

Private Equity Investor

Miscellaneous Commercial Services

Brian Strem

Eric Daniels

Founder

Founder

Miscellaneous Commercial Services

Jay Lichter

Stefan Heller

Director/Board Member

Director/Board Member

JANUX THERAPEUTICS, INC. Biotechnology

Jay Lichter

Stefan Heller

Chairman

Director/Board Member

Bayon Therapeutics, Inc.

Brian Strem

Eric Daniels

Founder

Founder

Investment Managers

Shane Battier

Private Equity Analyst

Restaurants

Shane Battier

Director/Board Member

Medical/Nursing Services

Anthony Williams

Director/Board Member

Medical Specialties

Anthony Williams

Director/Board Member

Biotechnology

Stefan Sperl

Founder

Statistik

International

Vereinigte Staaten 45
Japan 3
Vereinigtes Königreich 2
Russland 2
Österreich 2

Sektoral

Consumer Services 15
Health Technology 14
Finance 10
Commercial Services 6
Health Services 4

Operativ

Director/Board Member 299
Corporate Officer/Principal 168
Undergraduate Degree 87
Chief Executive Officer 59
Independent Dir/Board Member 57
  1. Börse
  2. Insiders
  3. Carmine Stengone
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT